Table 2.

The risk model of 12 BCSC-related lncRNAs with prognostic value in breast cancer

LncRNA	Coef	HR	HR.95L	HR.95H	p-value	Risk
AL122010.1	− 0.488472	0.61356332	0.40085805	0.9391353	0.02450628	Low
AC245297.3	− 0.39251	0.6753596	0.51409558	0.88720971	0.00480743	Low
Z68871.1	0.675654	1.96531726	1.25113209	3.08718155	0.00336423	High
LINC00578	0.189555	1.20871114	1.02961181	1.41896451	0.0205253	High
LINC01871	− 0.397982	0.67167386	0.51597499	0.87435591	0.00309782	Low
AC097639.1	0.207522	1.23062483	0.94799722	1.59751257	0.11903949	High
AP000851.2	− 0.271595	0.7621631	0.59823533	0.97101016	0.02794552	Low
AP003119.3	0.190492	1.20984515	0.95504527	1.53262399	0.11439212	High
AP001207.3	0.274701	1.31613764	1.12443772	1.54051956	0.00062571	High
LINC00668	0.26132	1.29864313	1.08803894	1.55001251	0.00379653	High
AC022509.2	− 0.211675	0.80922784	0.64043779	1.02250321	0.07614398	Low
SEMA3B-AS1	− 0.466346	0.62729049	0.50223943	0.78347763	3.94E−05	Low

coef the coefficient of lncRNAs correlated with survival, HR hazard ratio, HR.95L low 95%CI of HR, HR.95H high 95%CI of HR